Barclays analyst Luke Sergott raised the firm’s price target on Thermo Fisher to $660 from $630 and keeps an Overweight rating on the shares post the Q4 results. The Q1 outlook seems very conservative from a growth perspective and Thermo is set for another year of beats and raises, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TMO:
- Thermo Fisher Scientific Earnings Report: Is it a Beat?
- Thermo Fisher CEO: Very excited about potential growth in China in 2023
- Thermo Fisher sees Q1 EPS over 20% of full-year total, consensus $5.41
- Thermo Fisher sees FY23 adjusted EPS $23.70, consensus $23.21
- Thermo Fisher reports Q4 adjusted EPS $5.40, consensus $5.19